SCHEMBL3777249

SCHEMBL3777249

CN(C)CCCC[Si](C)(C)Cl

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
DNM1 Q05193 3/20 0.42
KCNH2 Q12809 1/20 0.32
HRH4 Q9H3N8 2/20 0.31
HRH3 Q9Y5N1 2/20 0.31
SIGMAR1 Q99720 2/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
CA12 O43570 1/20 0.30
CA2 P00918 1/20 0.30
CA3 P07451 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA5A P35218 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30
CA14 Q9ULX7 1/20 0.30
CA5B Q9Y2D0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770900 0.92 ALDH1A1 (0.45) ALDH1A1TSHRDNM1TDP1CA12
SCHEMBL3770386 0.84 ALDH1A1 (0.50) ALDH1A1TSHRDNM1KCNH2HRH4
SCHEMBL3771930 0.81 ALDH1A1 (0.53) ALDH1A1TSHRDNM1HRH4HRH3
SCHEMBL706918 0.80 ALDH1A1 (0.39) ALDH1A1
SCHEMBL28506154 0.78 ALDH1A1 (0.56) ALDH1A1TSHRDNM1HRH4HRH3
SCHEMBL3768534 0.77
SCHEMBL8158855 0.76 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8166184 0.76 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8166662 0.76 ALDH1A1 (0.36) ALDH1A1
SCHEMBL8169552 0.76 ALDH1A1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809464-B2 Polymers functionalized with halosilanes containing an amino group BRIDGESTONE CORPORATION (JP) 2014-08-19 US claimed
US-20120309906-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-12-06 US claimed
US-8258332-B2 Polymers functionalized with halosilanes containing an amino group BRIDGESTONE CORPORATION (JP) 2012-09-04 US claimed
US-20100317818-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP BRIDGESTONE CORPORATION (JP) 2010-12-16 US claimed
US-8809464-B2 Polymers functionalized with halosilanes containing an amino group BRIDGESTONE CORPORATION (JP) 2014-08-19 US disclosed
US-20120309906-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-12-06 US disclosed
US-8258332-B2 Polymers functionalized with halosilanes containing an amino group BRIDGESTONE CORPORATION (JP) 2012-09-04 US disclosed
US-20100317818-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP BRIDGESTONE CORPORATION (JP) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317818-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP MSN, PARG, ALG1 ALDH1A1 3885/4885TSHR 2843/4885DNM1 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.